536 related articles for article (PubMed ID: 31362427)
21. Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View.
Lambers Heerspink HJ; Gansevoort RT
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1079-88. PubMed ID: 25887073
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2.
Pedruzzi LM; Cardozo LF; Daleprane JB; Stockler-Pinto MB; Monteiro EB; Leite M; Vaziri ND; Mafra D
J Nephrol; 2015 Aug; 28(4):495-501. PubMed ID: 25585822
[TBL] [Abstract][Full Text] [Related]
23. [The management in chronic kidney disease (CKD)].
Busuioc M; Gusbeth-Tatomir P; Covic A
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):896-901. PubMed ID: 20209759
[TBL] [Abstract][Full Text] [Related]
24. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition.
Sung PH; Chen KH; Li YC; Chiang JY; Lee MS; Yip HK
Biomed Pharmacother; 2019 Mar; 111():1088-1102. PubMed ID: 30841422
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of nuclear factor-κB activity mediates CYP24 expression and reactive oxygen species production in indoxyl sulfate-induced chronic kidney disease.
Wang L; Gao Z; Wang L; Gao Y
Nephrology (Carlton); 2016 Sep; 21(9):774-81. PubMed ID: 26567049
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory Effects of the Nutraceutical Garlic Derivative Allicin in the Progression of Diabetic Nephropathy.
Arellano Buendía AS; Tostado González M; Sánchez Reyes O; García Arroyo FE; Argüello García R; Tapia E; Sánchez Lozada LG; Osorio Alonso H
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314265
[TBL] [Abstract][Full Text] [Related]
27. Magnesium in renal fibrosis.
Long M; Zhu X; Wei X; Zhao D; Jiang L; Li C; Jin D; Miao C; Du Y
Int Urol Nephrol; 2022 Aug; 54(8):1881-1889. PubMed ID: 35060008
[TBL] [Abstract][Full Text] [Related]
28. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
29. Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.
Vaziri ND; Liu S; Farzaneh SH; Nazertehrani S; Khazaeli M; Zhao YY
Free Radic Biol Med; 2015 Sep; 86():374-81. PubMed ID: 25930007
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical data.
Tomino Y
Kidney Blood Press Res; 2014; 39(5):450-89. PubMed ID: 25501571
[TBL] [Abstract][Full Text] [Related]
31. Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2.
Stenvinkel P; Chertow GM; Devarajan P; Levin A; Andreoli SP; Bangalore S; Warady BA
Kidney Int Rep; 2021 Jul; 6(7):1775-1787. PubMed ID: 34307974
[TBL] [Abstract][Full Text] [Related]
32. Transmembrane protein 126B protects against high fat diet (HFD)-induced renal injury by suppressing dyslipidemia via inhibition of ROS.
Weihong C; Bin C; Jianfeng Y
Biochem Biophys Res Commun; 2019 Jan; 509(1):40-47. PubMed ID: 30580996
[TBL] [Abstract][Full Text] [Related]
33. Tangeretin ameliorates renal failure via regulating oxidative stress, NF-κB-TNF-α/iNOS signalling and improves memory and cognitive deficits in 5/6 nephrectomized rats.
Wu J; Zhao YM; Deng ZK
Inflammopharmacology; 2018 Feb; 26(1):119-132. PubMed ID: 28871498
[TBL] [Abstract][Full Text] [Related]
34. The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis.
Zhou LL; Cao W; Xie C; Tian J; Zhou Z; Zhou Q; Zhu P; Li A; Liu Y; Miyata T; Hou FF; Nie J
Kidney Int; 2012 Oct; 82(7):759-70. PubMed ID: 22622498
[TBL] [Abstract][Full Text] [Related]
35. Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis mice.
Tsai PY; Ka SM; Chao TK; Chang JM; Lin SH; Li CY; Kuo MT; Chen P; Chen A
Free Radic Biol Med; 2011 Jun; 50(11):1503-16. PubMed ID: 21376112
[TBL] [Abstract][Full Text] [Related]
36. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy.
Wijkström J; González-Quiroz M; Hernandez M; Trujillo Z; Hultenby K; Ring A; Söderberg M; Aragón A; Elinder CG; Wernerson A
Am J Kidney Dis; 2017 May; 69(5):626-636. PubMed ID: 28126239
[TBL] [Abstract][Full Text] [Related]
37. Oxidant Mechanisms in Renal Injury and Disease.
Ratliff BB; Abdulmahdi W; Pawar R; Wolin MS
Antioxid Redox Signal; 2016 Jul; 25(3):119-46. PubMed ID: 26906267
[TBL] [Abstract][Full Text] [Related]
38. Oxidative/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain.
Szalay CI; Erdélyi K; Kökény G; Lajtár E; Godó M; Révész C; Kaucsár T; Kiss N; Sárközy M; Csont T; Krenács T; Szénási G; Pacher P; Hamar P
PLoS One; 2015; 10(6):e0127090. PubMed ID: 26086199
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis.
Rende U; Guller A; Goldys EM; Pollock C; Saad S
J Physiol; 2023 Jul; 601(14):2801-2826. PubMed ID: 37227074
[TBL] [Abstract][Full Text] [Related]
40. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
Kim HJ; Vaziri ND
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]